Viguié Schmidt & Associés advised LFB, which enters into exclusive negotiations with Novartis regarding the proposed sale of CellforCure, a leading pharmaceutical establishment that specializes in the industrialization, process optimization and large scale GMP manufacturing of various cell and gene therapy products for bio-pharmaceutical companies.
Members of the team involved in the transaction:
- François Bourrier-Soifer
- Christel Alberti
- Etienne Gouesse
- Alexandre Piette
- Camille Pedrini
- Maxence Dubois